EP1723052A1 — A fluid dispensing device
Assigned to Glaxo Group Ltd · Expires 2006-11-22 · 19y expired
What this patent protects
The present invention relates to a fluid dispensing device (1405) for dispensing a fluid product having a dispensing outlet (1411) from which the fluid product is dispensable, a supply of the fluid product, a dispensing member (1430) mounted for movement in a dispensing direction…
USPTO Abstract
The present invention relates to a fluid dispensing device (1405) for dispensing a fluid product having a dispensing outlet (1411) from which the fluid product is dispensable, a supply of the fluid product, a dispensing member (1430) mounted for movement in a dispensing direction along an axis X-X from a first position to a second position which causes a dose of the fluid product in the supply to be dispensed from the dispensing outlet, and a finger-operable actuator member (1420) mounted for movement in an actuating direction which is generally transverse to the axis. The actuator member has at least one cam surface (1422) and the dispensing member has at least one cam follower surface (1492). The at least one cam surface has a commitment section (1423a), oriented at a first angle to the axis, and an adjacent drive section (1423b), which is oriented at a second angle to the axis which is greater than the first angle.
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.